Move over Denver, Adam Bierman Chief Executive Officer of cannabis investment firm MedMenCapital believes that the City of Angels will steal the spotlight from the mile high city. Bierman said that by some estimates, Los Angeles’s medical marijuana market alone is already close to $1 billion, easily overshadowing Colorado’s entire market. The city is expected to pass an ordinance in 2017 that will clear the path for a proper licensing program and open up the recreational market. Bierman said that capital is flowing into the area for local ventures as investors begin to smell money in the emerging market.
Bierman believes that in 2017 a major sports league will approve the use of cannabis, at least for medicinal purposes. Many professional athletes have turned to using cannabis to treat pain and head injuries and are rejecting prescribed opiates. With medical marijuana legal in 29 states, the players are pushing to be treated just like other patients.
With many polls showing that most American’s approve of legalizing marijuana, it won’t be long before a major network will use marijuana as a backdrop. It’s been over decade since Showtime had a hit with its show Weeds. That series focused on a suburban mom that sold pot to make ends meet. It was considered ground breaking at the time with its taboo topic. Now HBO has High Maintenance and MTV’s got Mary + Jane. Adam Scott from Parks and Recreation got a green light from NBC to develop the script Buds based on a dispensary in Denver. There isn’t any timeline yet as to when the comedy could hit the air waves.
With the Hemp Industries Association and the DEA battling over the legality of cannabis extracts like cannabinoids or CBD, there is an expectation for increased interest in synthetic cannabinoids. Seth Yakatan, the chief executive officer of biotech company Kalytera said, “With AG Sessions and the DEA’s clarification that plant derived CBD isn’t legal federally, there will likely be interest in synthetic forms of CBD, which is what Kalytera has been testing the efficacy of for a few years.” Aside from the debate over whether CBD is legal or not, Yakatan is right that synthetic products do not have the legal limitations of other products. However, the synthetic products are not believed to be as effective as the natural products according to some patients. Fear over legal issues could create more demand for the synthetics.
Sasha Kadey, Chief Marketing Officer of vaporizer distributor Greenlane said he expects that as market supplies grow, prices will fall causing a commoditizing effect. “This is leading to premiumization.,” he said. “Much like the alcohol industry experienced during its maturation, with producers now seeking to differentiate with premium packaging, brand building, so called “seed to sale” storytelling, and other value adds.” Other growers will stress their organic features, while some will push celebrity endorsements. It will be the year of the craft bud.
The Cannabis Business Alliance or CBA is hoping to work with lawmakers to create options for marijuana that fails pesticide testing. Currently marijuana producers have to destroy crops that fail testing. The CBA is working towards a new rule to allow for these harvests to be turned into solvent-based concentrates that would be considered safe.